Previous 10 | Next 10 |
World’s first combination of tumor-targeted, off-the-shelf PD-L1-targeted Natural Killer cells with IL-15 fusion protein (N-803) to induce immune system activation of both the NK and T-cells demonstrated complete response in second-line metastatic pancreatic cancer, confirmed by PET...
Nantkwest (NASDAQ: NK ) exploded +91% in today's trade, thanks to a late surge after CEO Patrick Soon-Shiong told Bloomberg that the company's experimental cancer therapy achieved a complete response in one patient with pancreatic cancer during an early-stage clinical trial. More news ...
Gainers: BGFV +28.1% . MX +14.5% . ICHR +11.9% . MMSI +8.2% . PHAS +6.9% . More news on: Big 5 Sporting Goods Corporation, MagnaChip Semiconductor Corporation, Ichor Holdings, Ltd., Stocks on the move, , News on ETFs Read more ...
It looks as if the market has finally recognized the potential investment opportunity NantKwest ( NK ) has to offer. During the past three months, NK has climbed more than 150% to hit a new 52-week high of $3.58. This strong move to the upside has been fueled by impressive data releases and ...
Introduction I have written about companies working on research and development of cell therapies as the next frontier in cancer treatment. Current approved treatments such as CAR Ts are autologous treatments and require complex personalised manufacturing and can't be scaled up, which, i...
Gainers: ASLN +8.6% . NK +7.1% . SCS +5.5% . OBSV +2.8% . CTAS +2.8% . More news on: ASLAN Pharmaceuticals Limited, NantKwest, Inc., Steelcase Inc., Stocks on the move, , News on ETFs Read more ...
Gainers: Kaixin Auto (NASDAQ: KXIN ) +32% . More news on: Kaixin Auto Holdings, NantKwest, Inc., Renewable Energy Group, Inc., Stocks on the move, Read more ...
These Penny Stocks Hit Fresh Highs In December; Are They Still A Buy? One of the most important things to keep in mind with penny stocks is the fact that these stocks can generate enormous returns for investors. In 2019, many penny stocks have managed to see such returns in a very short pe...
Wave Life Sciences WVE -52% . More news on: Gossamer Bio, Inc., PG&E Corporation, NantKwest, Inc., , Stocks on the move Read more ...
NantKwest (NASDAQ: NK ) announces positive results from a Phase 1b clinical trial evaluating the combination of its antibody-targeted NK cells, ImmunityBio's N-803 (an IL-15 superagonist), low-dose chemo, adenoviral and yeast tumor-associated antigen vaccines (MUC1, brachyury, CEA) and a...
News, Short Squeeze, Breakout and More Instantly...
NantKwest Company Name:
NK Stock Symbol:
NASDAQ Market:
Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility PR Newswire A TotalEnergies solar and battery storage solution to bring 130-year-old Lompoc industrial site into new era of sustainability and smart energy manag...
Creates Leading Immunotherapy and Cell Therapy Company ImmunityBio , Inc. and NantKwest , Inc. ( NASDAQ: NK ), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditi...
NantKwest, Inc . ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger of NantKwest and ImmunityBio, Inc. presented at the special ...